Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

0.7800
+0.094913.85%
Post-market: 0.7674-0.0126-1.62%19:59 EDT
Volume:3.39M
Turnover:2.63M
Market Cap:123.75M
PE:-0.70
High:0.8100
Open:0.6850
Low:0.6850
Close:0.6851
52wk High:2.45
52wk Low:0.3772
Shares:158.65M
Float Shares:128.00M
Volume Ratio:3.56
T/O Rate:2.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1193
EPS(LYR):-1.8600
ROE:-778.33%
ROA:-74.57%
PB:-74.32
PE(LYR):-0.42

Loading ...

Fractyl Health Spotlights Remain-1 Data Showing Revita Maintains 84% of GLP-1 Weight Loss in Optimized Cohort

Reuters
·
Aug 20

Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance

GlobeNewswire
·
Aug 20

Fractyl Health Announces Special Stockholder Meeting

Reuters
·
Aug 15

UK's Mereo BioPharma Q2 Loss Narrows on Lower R&D Spending

Reuters
·
Aug 11

Morgan Stanley Keeps Their Hold Rating on Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Aug 11

Fractyl Health, Inc. (GUTS) Receives a Buy from Bank of America Securities

TIPRANKS
·
Aug 11

Fractyl Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Fractyl Health reports Q2 EPS (16c), consensus (14c)

TIPRANKS
·
Aug 11

Palisade Bio Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Fractyl Health Q2 FY26 Net Loss Narrows to $25.5 Million; Adjusted Ebitda Loss Improves to $16.3 Million

Reuters
·
Aug 11

Fractyl Health Q2 EPS $(0.16) Misses $(0.13) Estimate

Benzinga Earnings
·
Aug 11

Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates

GlobeNewswire
·
Aug 11

Fractyl Health, Inc. Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Fractyl Health to Report Q2 Results, Host Conference Call

Reuters
·
Aug 04

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

THOMSON REUTERS
·
Aug 04

Fractyl Health to Participate in Upcoming Investor Events

GlobeNewswire
·
Jul 23

Hold Rating Reaffirmed as Revita Data Show Promise but Risks and Valuation Keep Price Target Unchanged at $2

TIPRANKS
·
Jul 16

Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV)

TIPRANKS
·
Jul 16

Fractyl Health reports results from REMAIN-1 Midpoint Cohort

TIPRANKS
·
Jul 15

Fractyl Health Says Revita Cuts Weight Regain vs Sham One Year After GLP-1 Discontinuation in Remain-1 Trial

Reuters
·
Jul 15